Tag: G-CSF Biosimilars Market

G-CSF Biosimilars Market Size, Trends and Opportunities The G-CSF biosimilars market has witnessed significant growth in recent years, driven by increasing demand for cost-effective alternatives to branded biologics. G-CSF (Granulocyte Colony-Stimulating Factor) is primarily used in the treatment of neutropenia, a condition often induced by chemotherapy. With the expiration of patents for several original G-CSF […]